Obchod ACAD

ACADIA Pharmaceuticals Inc

-

00:00:00

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. It’s pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer’s disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer’s. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Více informací...

ACAD
Obchodní specifikace

Číslice

3

Bod

0.001

Spread

floating

Velikost smlouvy

1

Objem min.

1

Maximální objem

10,000

Krok svazku

1

Výměna dlouhých (bodů)

-3.790

Swap Short (body)

-2.200
K dispozici na
MT5, TV, cTrader
Poslední aktualizace v 4 prosince, 21:09 GMT+3
*Zdroj dat: MT5 Server Prime Account Pricing

ACAD
Ekonomický kalendář

Nebyly nalezeny žádné údaje

1D Změna

5.165%

Proč BlackBull Markets?

26k+

Obchodovatelná aktiva

1:500

Pákový efekt až do

Regulované stránky

Víceregulátorové

24/7

Zákaznická podpora

$0

Žádný minimální vklad

Kalkulačka marže

Calculation Results

Current Price

17.12

Required Margin

Converted Currency

Required Margin

Account Base Currency

Kalkulačka zisku/ztráty

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Kalkulačka swapů

Calculation Results

17.12

Obchodní příležitosti

Nebyly nalezeny žádné údaje
Join Now